Shanghai Fosun Pharmaceutical (Group) Co Ltd (SFOSF)
1.55
+0.02
(+1.17%)
USD |
OTCM |
Apr 29, 16:00
Shanghai Fosun Pharmaceutical Debt to Equity Ratio: 0.7237 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7237 |
| September 30, 2023 | 0.7092 |
| June 30, 2023 | 0.725 |
| March 31, 2023 | 0.6618 |
| December 31, 2022 | 0.6618 |
| September 30, 2022 | 0.6769 |
| June 30, 2022 | 0.767 |
| March 31, 2022 | 0.6787 |
| December 31, 2021 | 0.602 |
| September 30, 2021 | 0.5993 |
| June 30, 2021 | 0.6139 |
| March 31, 2021 | 0.6177 |
| December 31, 2020 | 0.6322 |
| September 30, 2020 | 0.7373 |
| June 30, 2020 | 0.6892 |
| March 31, 2020 | 0.6883 |
| December 31, 2019 | 0.6742 |
| September 30, 2019 | 0.7914 |
| June 30, 2019 | 0.7967 |
| March 31, 2019 | 0.8165 |
| December 31, 2018 | 0.8362 |
| September 30, 2018 | 0.8151 |
| June 30, 2018 | 0.9034 |
| March 31, 2018 | 0.8292 |
| December 31, 2017 | 0.8012 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.7833 |
| June 30, 2017 | 0.6237 |
| March 31, 2017 | 0.6113 |
| December 31, 2016 | 0.5057 |
| September 30, 2016 | 0.6191 |
| June 30, 2016 | 0.6298 |
| March 31, 2016 | 0.637 |
| December 31, 2015 | 0.5998 |
| September 30, 2015 | 0.6174 |
| June 30, 2015 | 0.4621 |
| March 31, 2015 | 0.4466 |
| December 31, 2014 | 0.4682 |
| September 30, 2014 | 0.5065 |
| June 30, 2014 | 0.4409 |
| March 31, 2014 | 0.4156 |
| December 31, 2013 | 0.3668 |
| September 30, 2013 | 0.3945 |
| June 30, 2013 | 0.4256 |
| March 31, 2013 | 0.3693 |
| December 31, 2012 | 0.3802 |
| September 30, 2012 | 0.59 |
| June 30, 2012 | 0.6059 |
| March 31, 2012 | 0.6412 |
| December 31, 2011 | 0.6245 |
| September 30, 2011 | 0.598 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5993
Minimum
Sep 2021
0.7967
Maximum
Jun 2019
0.6866
Average
0.6787
Median
Mar 2022
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 0.7819 |
| Zai Lab Ltd | 0.00 |
| I-MAB | 0.0174 |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 16.01B |
| Total Liabilities (Quarterly) | 8.020B |
| Shareholders Equity (Quarterly) | 6.445B |
| Current Ratio | 1.001 |
| Net Debt Paydown Yield | -1.81% |